KRRO · Korro Bio, Inc. · Investor Relations
$10.34
+1.05 (+11.30%)
At close · Oct 22
Return incl. dividend (before tax)
Market Cap
$136.80M
Shares
14.73M
Volume · Oct 22
58.83K
Avg daily vol (3M)
149.92K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-10 | 2026 Cantor Global Healthcare Conference | Conference |
| 2026-09-09 | Citi 2026 Biopharma Back to School Summit | Event |
| 2026-06-04 | 2026 Jefferies Global Healthcare Conference | Conference |
| 2026-05-27 | EASL Congress 2026 | Event |
| 2026-05-20 | 2026 RBC Capital Markets Global Healthcare Conference | Conference |
| 2026-05-19 | HCW 4th Annual BioConnect Nasdaq Investor Conference | Conference |
| 2026-05-15 | A GalNAc-conjugated RNA editing oligonucleotide achieves >90% editing of pathogenic SERPINA1 transcripts, restoring Alpha-1 Antitrypsin function in AATD models | Event |
| 2026-05-14 | TIDES USA 2026: Oligonucleotide and Peptide Therapeutics Conference | Conference |
| 2026-05-14 | American Society of Gene and Cell Therapy 29th Annual Meeting (ASGCT) | Shareholder meeting |
| 2026-04-24 | 3rd International Conference on Ureagenesis Defects and Allied Conditions | Conference |
Source: https://ir.korrobio.com/
Key facts
CIK
1703647
CUSIP
500946108
13F (30d)
12 filings
12 filers
Visit website
Investor relations